CHE · Chemed Corp · Metrics
$546.85
+0.13 (+0.02%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.12B
Shares
13.01M
Volume · Nov 19
24.83K
Avg daily vol (3M)
151.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CHE metrics
113 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$546.72
Market cap
$7.12B
Price action
23 metricsPrice change (1W)
-0.7%
Price change (30D)
+7.6%
Price change (3M)
+2.1%
Price change (6M)
+23.8%
Price change (YTD)
+27.8%
Price change (1Y)
+25.6%
Trailing year
Price change (5Y)
+8.8%
52-week high
$552.72
52-week low
$368.59
Change from 52-week high
-1.1%
Change from 52-week low
+48.3%
Annualized volatility
28.5%
Annualized volatility (3M)
22.6%
Implied volatility (30D)
28.3%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.1
RSI (14D)
59.3
Price vs SMA 50
+5.4%
Price vs SMA 200
+16.5%
Avg volume (3M)
151,712
Relative volume
1.1
Average dollar volume
$79.06M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
13.01M
Valuation
12 metricsP / E (TTM)
26.2
Trailing earnings · reciprocal yield 3.8%
PEG ratio
1.2
EV / revenue
2.7×
reciprocal yield 36.4%
EV / EBITDA
16.7×
reciprocal yield 6.0%
EV / EBIT
19.7×
reciprocal yield 5.1%
P / sales
2.7×
reciprocal yield 37.4%
P / book
8.3
reciprocal yield 12.1%
FCF yield
4.2%
TTM · current market cap
Buyback yield
7.4%
P / FCF
24.1
reciprocal yield 4.2%
P / operating cash flow
19.6
reciprocal yield 5.1%
Earnings yield
4.0%
Historical valuation
8 metricsP / E historical average (3Y)
26.7×
reciprocal yield 3.7%
P / E historical average (5Y)
28.3×
reciprocal yield 3.5%
EV / revenue historical average (3Y)
3.0×
reciprocal yield 33.6%
EV / revenue historical average (5Y)
3.2×
reciprocal yield 31.0%
EV / EBIT historical average (3Y)
20.5×
reciprocal yield 4.9%
EV / EBIT historical average (5Y)
21.3×
reciprocal yield 4.7%
EV / EBITDA historical average (3Y)
17.3×
reciprocal yield 5.8%
EV / EBITDA historical average (5Y)
18.1×
reciprocal yield 5.5%
Dividends & buybacks
7 metricsDividend yield
0.5%
Trailing 12 months
Payout ratio
11.9%
Shareholder yield
7.8%
Dividend / share (TTM)
$2.60
Dividend growth YoY
+18.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-11-16
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-28
Profitability
9 metricsGross margin
33.5%
Operating margin
13.9%
Trailing 12 months
Net margin
10.6%
Gross profit (TTM)
$892.52M
Operating profit (TTM)
$370.86M
Net income (TTM)
$282.40M
Trailing 12 months
Diluted EPS (TTM)
$20.87
FCF margin
11.1%
Effective tax rate
26.1%
Growth
11 metricsRevenue growth YoY
+10.6%
Year over year
Net income growth YoY
+11.5%
Revenue (TTM)
$2.66B
Trailing 12 months
EPS growth YoY
+22.2%
Shares change YoY
-8.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.8%
Revenue CAGR (5Y)
+4.0%
EPS CAGR (3Y)
+3.5%
EPS CAGR (5Y)
-1.2%
FCF CAGR (3Y)
+8.8%
FCF CAGR (5Y)
-5.4%
Quality
14 metricsReturn on equity
32.8%
Return on assets
16.4%
Debt / equity
0.3
Current ratio
1.1
EBITDA (TTM)
$438.45M
Free cash flow (TTM)
$295.59M
Quick ratio
1.1
Interest coverage
75.4
Net debt / EBITDA
0.4
Return on invested capital
26.1%
Trailing 12 months
Net cash
−$187.57M
Latest balance sheet
Cash & equivalents
$48.43M
Total assets
$1.72B
Total debt
$236.00M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$363.15M
Capital expenditures (TTM)
$67.56M
R&D (TTM)
—
SG&A (TTM)
$446.50M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
545
13F filer change QoQ
+11
Institutional ownership
102.4%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.1%
Holder tenure
17.6
Price vs estimated holder cost
+2.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
25.7%
Short interest
3 metricsShort interest
6.1%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
75 / 100
Insider activity
2 metricsNet insider buying (90D)
−$5.77M
Insider-sentiment score
16 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
19584
CUSIP
16359R103
13F (30d)
559 filings
500 filers
Visit website
Investor relations